{
    "clinical_study": {
        "@rank": "110894", 
        "arm_group": [
            {
                "arm_group_label": "painPREMIER cohort"
            }, 
            {
                "arm_group_label": "Control cohort"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this investigation is to determine whether the use of painPREMIER will\n      significantly improve function in patients with low back pain in an occupational health\n      clinical setting. painPREMIER is a tool that assists clinicians in the accurate diagnosis of\n      back pain and associated problems in order to treat them most effectively."
        }, 
        "brief_title": "Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Back Pain", 
        "condition_browse": {
            "mesh_term": [
                "Back Pain", 
                "Low Back Pain"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients presenting at feeder sites to be referred to low back pain clinic and assessed for\n      eligibility A decision was made to terminate this study on 09 OCT 2013. The study was\n      terminated for operational/business reasons. This study was not terminated for reasons of\n      safety or efficacy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  New episode of low back pain\n\n          -  Member of Terveystalo health insurance scheme\n\n        Exclusion Criteria:\n\n          -  Previous back pain related healthcare visit in the last 3 months\n\n          -  Patients identified as having a 'red flag' condition"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Members of the Terveystalo health insurance scheme presenting with a new episode of low\n        back pain"
            }
        }, 
        "enrollment": {
            "#text": "86", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01787565", 
            "org_study_id": "X9001016"
        }, 
        "intervention": [
            {
                "arm_group_label": "painPREMIER cohort", 
                "description": "Low back pain patients prospectively recruited during the study period and managed with painPREMIER.", 
                "intervention_name": "painPREMIER cohort", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Control cohort", 
                "description": "A matched group of low back pain patients not managed with painPREMIER.", 
                "intervention_name": "Control cohort", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "non-interventional", 
            "clinical", 
            "investigation", 
            "low", 
            "back", 
            "pain", 
            "painPREMIER"
        ], 
        "lastchanged_date": "February 12, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=X9001016&StudyName=Pilot%20Evaluation%20to%20Assess%20the%20Clinical%20and%20Economic%20Impact%20of%20Pfizer%u2019s%20Pain%20Management%20Program%20%28painPREMIER%29%20in%20the%20Treatment%20of"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Helsinki", 
                    "country": "Finland", 
                    "zip": "00100"
                }, 
                "name": "Pfizer Investigational Site"
            }
        }, 
        "location_countries": {
            "country": "Finland"
        }, 
        "number_of_groups": "2", 
        "official_title": "Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland", 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "Finland: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Change from baseline", 
            "measure": "Roland Morris Disability Questionnaire", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01787565"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Change from baseline", 
                "measure": "Roland Morris Disability Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Change from baseline", 
                "measure": "Self-reported low back pain intensity", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Proportion of patients with at least 30% and 50% improvement", 
                "measure": "Self-reported low back pain intensity and Roland Morris Disability Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Change from baseline", 
                "measure": "Global Assessment of Disease Activity", 
                "safety_issue": "No", 
                "time_frame": "any time up to 6 months"
            }, 
            {
                "description": "Change from baseline", 
                "measure": "SF-12 (Short Form 12 Health Survey), v2.0 (Mental Component Summary Scale and Physical Component Summary Scale)", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Change from baseline", 
                "measure": "EQ5-D Health Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Proportion of patients at risk for depression and/or anxiety", 
                "measure": "PHQ-4 (Patient Health Questionnaire for Depression and Anxiety-4)", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Changes from baseline (if collected at BL)", 
                "measure": "Self-reported depression PHQ-8 (Patient Health Questionnaire for Depression and Anxiety-8) and anxiety GAD-7 (Generalized Anxiety Disorder 7-item scale)", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Changes from baseline", 
                "measure": "Self-reported catastrophizing -  Coping Strategies Questionnaire - Catastrophizing scale (CSQ-CAT)", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Changes from baseline", 
                "measure": "Self-reported absenteeism, presenteeism, lost productivity and activity, over prior 2 weeks, measured by Work Productivity and Activity Impairment (WPAI): Specific Helath Problem (Low Back Pain) questionnaire (painPREMIER cohort)", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Comparison between painPREMIER cohort and control cohort", 
                "measure": "All-cause absence days and costs associated with sick leave", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Comparison of pre and post-enrollment for both cohorts", 
                "measure": "All-cause pharmacy and medical resource use/costs", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Comparison of pre and post-enrollment for both cohorts", 
                "measure": "Low back pain-related medical resource use/costs and pharmacy use/costs", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Comparison of pre and post-enrollment for both cohorts", 
                "measure": "Low back pain-specific medical resource use/costs", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Comparison of pre and post-enrollment for both cohorts", 
                "measure": "Total low back pain direct medical costs", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Comparison between painPREMIER and control cohort", 
                "measure": "Overall low back pain costs via claims data and imputed WPAI:LBP Work Productivity and Activity Impairment (WPAI): Specific Helath Problem (Low Back Pain) questionnaire", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Comparison between painPREMIER and control cohort", 
                "measure": "Overall all costs via claims and absence data", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Patient Satisfaction with painPREMIER", 
                "measure": "Patient Satisfaction", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Specialist Occupational Health Provider Satisfaction with painPREMIER", 
                "measure": "Specialist Occupational Health Provider Satisfaction", 
                "safety_issue": "No", 
                "time_frame": "After enrolment complete estimated 4 months"
            }, 
            {
                "description": "Net Promoter Score", 
                "measure": "Net Promoter Score", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }, 
            {
                "description": "Patient feedback", 
                "measure": "Semi-structured interview", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Specialist Occupational Health Provider Engagement with portal", 
                "measure": "Specialist Occupational Health Provider Engagement", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Specialist Occupational Health Provider treatment recommendations vs painPREMIER treatment recommendations", 
                "measure": "Specialist Occupational Health Provider treatment recommendations", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Platform use, CBST(Cognitive Behavioral Skills Training) module use and adherence to pharmacological therapy", 
                "measure": "Patient engagement/treatment adherence", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "To evaluate the correlation between TAMPA17, PHQ4, PHQ8, GAD7 baseline assessments in the painPREMIER cohort", 
                "measure": "TAMPA17 Scale for Kinesiophobia, PHQ4, PHQ8, (Patient Health Questionnaire for Depression and Anxiety-4 and 8), GAD7 (Generalized Anxiety Disorder 7-item scale)", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "To evaluate the change from baseline and correlation between the instruments in the painPREMIER cohort", 
                "measure": "painDETECT, TAMPA17 Scale for Kinesiophobia, LBPI (low back pain intensity) and RMDQ (Roland Morris Disability Questionnaire)", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "To evaluate patterns of use and outcomes in subgroups", 
                "measure": "Sub-group analysis", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Change from baseline", 
                "measure": "Daily sleep intereference rating scale", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Change from baseline", 
                "measure": "Daily sleep intereference rating scale", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Proportion of patients with at least 30% and 50% improvement", 
                "measure": "Self-reported low back pain intensity and Roland Morris Disability Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Change from baseline", 
                "measure": "SF-12 (Short Form 12 Health Survey), v2.0 (Mental Component Summary Scale and Physical Component Summary Scale)", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Change from baseline", 
                "measure": "EQ5-D Health Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Proportion of patients at risk for depression and/or anxiety", 
                "measure": "PHQ-4 (Patient Health Questionnaire for Depression and Anxiety-4)", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Changes from baseline (if collected at BL)", 
                "measure": "Self-reported depression PHQ-8  (Patient Health Questionnaire for Depression and Anxiety-8) and anxiety GAD-7 (Generalized Anxiety Disorder 7-item scale)", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Change from baseline", 
                "measure": "Self-reported catastrophizing (CSQ-CAT) Coping Strategies Questionnaire - Catastrophizing scale", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Changes from baseline", 
                "measure": "Self-reported absenteeism, presenteeism, lost productivity and activity, over prior 2 weeks, measured by Work Productivity and Activity Impairment (WPAI): Specific Helath Problem (Low Back Pain) questionnaire (painPREMIER cohort)", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Comparison between painPREMIER cohort and control cohort", 
                "measure": "All-cause absence days and costs associated with sick leave", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Comparison of pre and post-enrollment for both cohorts", 
                "measure": "All-cause pharmacy and medical resource use/costs", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Comparison of pre and post-enrollment for both cohorts", 
                "measure": "Low back pain-related medical resource use/costs and pharmacy use/costs", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Comparison of pre and post-enrollment for both cohorts", 
                "measure": "Low back pain-specific medical resource use/costs", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Comparison of pre and post-enrollment for both cohorts", 
                "measure": "Total low back pain direct medical costs", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Comparison between painPREMIER and control cohort", 
                "measure": "Overall low back pain costs via claims data and imputed WPAI:LBP Work Productivity and Activity Impairment (WPAI): Specific Helath Problem (Low Back Pain) questionnaire", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Comparison between painPREMIER and control cohort", 
                "measure": "Overall all costs via claims and absence data", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Patient Satisfaction with painPREMIER", 
                "measure": "Patient Satisfaction", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Net Promoter Score", 
                "measure": "Net Promoter Score", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Pfizer", 
        "sponsors": {
            "collaborator": {
                "agency": "Terveystalo", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014", 
        "why_stopped": "See termination reason in detailed description."
    }
}